Bridgeway Capital Management, LLC Aadi Bioscience, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.24 Billion
- Q4 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 115,400 shares of AADI stock, worth $228,492. This represents 0.01% of its overall portfolio holdings.
Number of Shares
115,400
Previous 93,300
23.69%
Holding current value
$228,492
Previous $192,000
89.58%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AADI
# of Institutions
57Shares Held
15.6MCall Options Held
15KPut Options Held
3.1K-
Avoro Capital Advisors LLC New York, NY2.85MShares$5.64 Million0.13% of portfolio
-
Qvt Financial LP New York, NY2.31MShares$4.58 Million0.72% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.1MShares$4.16 Million4.12% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$3.66 Million8.31% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.15MShares$2.27 Million1.96% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $41.6M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...